MANGALAM — Mangalam Drugs and Organics Cashflow Statement
0.000.00%
- IN₹1.23bn
- IN₹2.04bn
- IN₹3.18bn
- 84
- 84
- 28
- 76
Annual cashflow statement for Mangalam Drugs and Organics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | R2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | PRESS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 395 | 277 | 22.1 | 39.7 | 47.9 |
Depreciation | |||||
Non-Cash Items | 80.6 | 121 | 129 | 64.5 | 140 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -292 | -244 | 134 | -140 | 72.1 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 275 | 257 | 395 | 39.1 | 426 |
Capital Expenditures | -314 | -277 | -279 | -118 | -202 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 1.51 | 3.43 | 57.4 | 0.053 | 7.29 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -313 | -273 | -222 | -118 | -195 |
Financing Cash Flow Items | -93.3 | -112 | -128 | -72.6 | -149 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 27 | 29.8 | -166 | 52.3 | -217 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -10.4 | 13.6 | 7.34 | -26.9 | 14.1 |